Amwell Executives to Take the Stage at ViVE 2024

Rhea-AI Summary

Amwell executives to discuss hybrid care enablement and virtual care delivery at VIVE 2024 conference. Roy Schoenberg to moderate a panel on digital-first care delivery, while Cynthia Horner will participate in a discussion on GLP-1s.

Company leaders to moderate or speak at sessions on virtual care delivery, GLP-1s

Boston, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, will attend VIVE 2024, Feb. 25-28, in Los Angeles. Executives will be onsite to discuss the company’s hybrid care enablement platform, virtual nursing, automated care, and digital behavioral health programs and how technology can address workforce shortages, access to care, the mental health crisis and other industry issues. 

In addition, two Amwell executives will lead or participate in ViVE panels: 

• Roy Schoenberg, M.D., M.P.H., Amwell president and co-CEO, will moderate the panel: Freaky Friday: Swapping Hospital-Based Care with Virtual Modalities at 9 a.m. PST, Monday, Feb. 26 on the Downtown LA stage.  

Schoenberg will lead a discussion with leaders from Providence, NewYork-Presbyterian, and Froedtert & Medical College of Wisconsin and Inception Health. The conversation will center on digital-first care delivery using tools such as remote monitoring devices and wearable technology to foster a more proactive and personalized approach to healthcare outside the hospital setting. 

• Cynthia Horner, M.D., Amwell chief medical officer, will participate in the panel: From Hospital to Hollywood: The Rise of GLP-1s at 9 a.m. PST, Tuesday, Feb. 27 on the Sunset Strip stage.  

Horner will join colleagues from Amazon Pharmacy, knownwell, and Vida Health, for a discussion about whether the industry can create a sustainable model to cover the costs of GLP-1s, virtual primary care as a healthcare solution for weight-related co-morbidities and curbing the trajectory of obesity rates.   

For more information about Amwell at ViVE or to talk with a company leader during the event, contact press@amwell.com. 

 About Amwell   

Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.   

 ©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.   

FAQ

What will Amwell executives be discussing at VIVE 2024?

Amwell executives will discuss the company's hybrid care enablement platform, virtual nursing, automated care, and digital behavioral health programs at VIVE 2024.

Who will moderate the panel on digital-first care delivery at the conference?

Roy Schoenberg, M.D., M.P.H., Amwell president and co-CEO, will moderate the panel on digital-first care delivery at VIVE 2024.

What will the panel discussion on GLP-1s focus on?

The panel discussion on GLP-1s will focus on the rise of GLP-1s and will include Cynthia Horner, M.D., Amwell chief medical officer, along with colleagues from Amazon Pharmacy, knownwell, and Vida Health.